SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 696.21 |
| Enterprise Value ($M) | -115.68 |
| Book Value ($M) | 1,110.98 |
| Book Value / Share | 2.90 |
| Price / Book | 0.63 |
| NCAV ($M) | 880.78 |
| NCAV / Share | 2.30 |
| Price / NCAV | 0.79 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.04 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 18.17 |
| Current Ratio | 18.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 936.11 |
| Assets | 1,166.31 |
| Liabilities | 55.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 117.61 |
| Operating Income | -54.27 |
| Net Income | 41.08 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 18.84 |
| Cash from Investing | 175.15 |
| Cash from Financing | -1.23 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Altria Group, Inc. | 41.00 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 408,790 | 2,037,431 | 20.06 | |
| 292,586 | 1,187,215 | 24.64 | |
| 357,427 | 1,052,599 | 33.96 | |
| 211,146 | 805,600 | 26.21 | |
| 273,961 | 1,016,590 | 26.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CLYM – Climb Bio, Inc. | CMRX – Chimerix, Inc. |
| CRMD – CorMedix Inc. | CRSP – CRISPR Therapeutics AG |
| CRVS – Corvus Pharmaceuticals, Inc. |